Private Equity & Private Capital News

Apheon, a pan-European mid-market private equity investment company, has closed a continuation fund for TMC and Haudecoeur – two high-performing assets held in its MidCap Buyout IV SCSp (AMB IV) – at €435m, with backing from HarbourVest as lead investor.

Singapore Post Limited (SingPost), the Asia Pacific-based postal and eCommerce logistics provider, is to sell its Australian business, Freight Management Holdings (FMH) to private equity firm Pacific Equity Partners (PEP) for AUD775.9m ($505.4m).

Private equity giant GTCR has committed to a $1.33bn investment in software testing leader Tricentis, supported by the current majority owner Insight Partners, in a deal that values the business at $4.5bn.

KKR, the Canada Pension Plan Investment Board (CPPIB), and Axel Springer CEO Mathias Döpfner are working to secure approximately €4bn ($4.2bn) in debt to finance a strategic separation of the German media giant’s classified ads businesses from its news operations, according to a report by Bloomberg.

Equistone Partners Europe (Equistone), one of Europe’s most established mid-market private equity investors, has completed its €520m sale of Groupe Courir (Courir), a leading French retailer of sports shoes, to JD Sports Fashion.

A consortium led by private investment firms Starwood Capital Group and Warburg Pincus is working to finalise a deal to take ESR Group private, valuing the Hong Kong-listed real estate fund manager at over $7bn, according to a report by Reuters.

Montana Capital Partners hat seine jüngste Investorenumfrage veröffentlicht, in der die Anlagepräferenzen globaler Private-Equity-Investoren untersucht werden. „Die Ergebnisse unterstreichen das anhaltende Wachstum und die Attraktivität der Anlageklasse“, betont Marco Wulff, CEO bei Montana Capital Partners.

Despite rising geopolitical tensions, PE allocations remain high with 30% of institutional investors and 76% of family offices reporting allocating more than 15% of their portfolio to the asset class, a rise of 7% and 4% respectively, compared to 2023.

CVC Capital Partners, the majority shareholder of Italy’s pharmaceutical group Recordati, has reportedly initiated discussions with other Italian drugmakers regarding a potential sale, according to a report by Reuters citing Sergio Dompe, CEO of rival firm Dompé Farmaceutica.